4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|4|1024-1036

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.4, 2015-10, pp. : 1024-1036

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1024-1036

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adefovir and Lamivudine Combination Therapy in Patients with Entecavir-Resistant Chronic Hepatitis B: Antiviral Responses and Evolution of Mutations

By  

Intervirology, Vol. 57, Iss. 5, 2014-06 ,pp. : 239-247

Karger

Access to resources Recommend Favorite

Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2370-2383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Simultaneous Emergence of Entecavir Resistance Mutations in a Nucleoside-Naive Chronic Hepatitis B Patient

By  

Intervirology, Vol. 55, Iss. 5, 2012-04 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug‐resistant strains of hepatitis B virus

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 1478-3223, Iss. 10, 2015-10 ,pp. : 2265-2274

John Wiley & Sons Inc

Access to resources Recommend Favorite